Spouting Rock Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$990K Buy
7,978
+2,638
+49% +$269K 0.36% 56
2023
Q3
$498K Buy
5,340
+619
+13% +$69.8K 0.16% 87
2023
Q2
$607K Buy
4,721
+71
+2% +$8.59K 0.22% 87
2023
Q1
$540K Buy
+4,650
New +$521K 0.19% 96
2021
Q3
Sell
-2,164
Closed -$231K 134
2021
Q2
$231K Buy
+2,164
New +$208K 0.07% 195

Other funds holding DXCM

Spouting Rock Asset Management's DXCM Position: Q4 2023 in Review

Spouting Rock Asset Management increased its DexCom (DXCM) stake by 49% in Q4 2023, buying an estimated $269K and bringing the position to 7,978 shares worth $990K. The position accounts for 0.36% of the portfolio, ranked #56.

Spouting Rock Asset Management first reported a position in DXCM in Q2 2021 and has held it in 5 quarters since. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Spouting Rock Asset Management held 7,978 shares of DexCom worth $990K as of Q4 2023.
  • Spouting Rock Asset Management bought 2,638 DexCom shares in Q4 2023, an estimated $269K.
  • DexCom made up 0.36% of Spouting Rock Asset Management's portfolio in Q4 2023, its #56 holding.
  • Spouting Rock Asset Management first reported a position in DexCom in Q2 2021 and has held it in 5 quarters since.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Spouting Rock Asset Management's 13F filing for Q4 2023, filed 16 Feb 2024.